Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

It would work, for a while, and she would lose some weight. Ultimately, however, “I couldn’t get over the obsession with food ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

A TikTokker posting under the name @JonBoy_LosesIt has shared his attitude to the loose skin he's been left with after losing ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

A recent study reveals that weight tends to be regained after discontinuing anti-obesity medications (AOMs) such as Ozempic, despite initial successful weight loss.

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international ...